Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


High-risk women need more frequent doses of HIV drugs

Researchers say more frequent pre-exposure prophylaxis is required to protect women from HIV.

Micrograph of human immunodeficiency virus (HIV) virions

Source: CDC / Dr A Harrison, Dr P Feorino

Transmission of HIV (pictured) can be reduced through prophylaxis, but men and women may need different doses to provide protection

Pre-exposure prophylaxis is highly effective at reducing HIV transmission to people at high risk, such as men who have sex with men. But studies in high-risk women have produced mixed results. 

To explore why, researchers from the University of North Carolina studied vaginal, cervical and colorectal tissue samples from 47 healthy women following the administration of tenofovir/emtricitabine at 50–200% of the standard treatment dose. 

Tenofovir concentration was ten times higher in colorectal tissue than in vaginal or cervical tissue. Furthermore, levels of endogenous nucleotides, which can interfere with antiviral effectiveness, were also higher in the genital tract. 

Subsequently, the researchers predict in the Journal of Infectious Diseases (online, 24 February 2016)[1] that six out of seven daily doses are required for protection from HIV in the female genital tract compared with only two out of seven doses for colorectal tissue.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20200831

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Micrograph of human immunodeficiency virus (HIV) virions

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.